Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma
NCT00543686 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2009-02-04
Summary
Explorative comparison of montelukast with inhaled steroids (fluticasone) to estimate responder profiles, in terms of symptom scores, rescue medication, increase of FEV1, in correlation to presence of allergy, bronchial hyperreactivity (PD20), exhaled NO, excretion of leukotrienes, response to RABA and laboratory parameters in patients with pre-school asthma i.e. asthma phenotypes.
Conditions
Interventions
- DRUG
-
Montelukast
Intake of Montelukast
- DRUG
-
Fluticasone
Intake of Fluticasone
Sponsors & Collaborators
-
Johann Wolfgang Goethe University Hospital
lead OTHER
Principal Investigators
-
Stefan Zielen, Prof. Dr. · Johann Wolfgang Goethe-University Frankfurt, Zentrum für Kinderheilkunde I, Haus 32, Abt. Pneumologie
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2009-01-31
- Completion
- 2009-02-28
Countries
- Germany
Study Locations
More Related Trials
-
Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children
NCT03369119 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
NCT00700661 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Montelukast in Children With Asthma
NCT00675285 ·Status: COMPLETED ·Phase: PHASE3
-
Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)
NCT00943397 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)
NCT00140881 ·Status: COMPLETED ·Phase: PHASE4
-
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
NCT00284856 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Montelukast in Asthma
NCT01011452 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Montelukast on Smokers With Asthma
NCT00712335 ·Status: COMPLETED ·Phase: PHASE4
-
Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)
NCT00943683 ·Status: COMPLETED ·Phase: NA
-
Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
NCT00446056 ·Status: COMPLETED ·Phase: PHASE4
-
Montelukast With Status Asthmaticus, Ages 6-18
NCT00494572 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)
NCT00832455 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Montelukast in Asthma in Children
NCT01266772 ·Status: UNKNOWN ·Phase: PHASE3
-
Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)
NCT00756418 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients
NCT00453778 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Two Treatment Regimens in Asthmatic Patients
NCT01488773 ·Status: COMPLETED
-
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710 ·Status: COMPLETED ·Phase: NA
-
Montelukast With Status Asthmaticus, Ages 2-5
NCT00491790 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial
NCT00156819 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
NCT01328964 ·Status: COMPLETED
-
Individualized Therapy For Asthma in Toddlers
NCT01606306 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness
NCT00913328 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)
NCT00636207 ·Status: COMPLETED ·Phase: PHASE1
-
Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )
NCT00968201 ·Status: COMPLETED ·Phase: PHASE3
-
Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test
NCT01759472 ·Status: UNKNOWN